You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Recombinant Human Insulin
Contributor:
Ladisch, Michael R.;
Kohlmann, Karen L.
imprint:
Wiley, 1992
Published in:Biotechnology Progress
Language:
English
DOI:
10.1021/bp00018a001
ISSN:
8756-7938;
1520-6033
Origination:
Footnote:
Description:
<jats:title>Abstract</jats:title><jats:p>Insulin is a well‐characterized peptide that can be produced by recombinant DNA technology for human therapeutic use. A brief overview of insulin production from both traditional mammalian pancreatic extraction and recombinant bacterial and yeast systems is presented, and detection techniques, including electrophoresis, are reviewed. Analytical systems for insulin separation are principally based on reversed‐phase chromatography, which resolves the deamidation product(s) (desamido insulin) of insulin, proinsulin, and insulin. Process‐scale separation is a multistep process and includes ion exchange, reversed‐phase, and size exclusion chromatography. Advantages and/or disadvantages of various separation approaches, as described by the numerous literature references on insulin purification, are presented.</jats:p>